Tyra Biosciences, Inc.
TYRA
$12.12
$0.423.59%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -50.24% | -54.72% | -12.01% | -13.54% | -40.91% |
Total Depreciation and Amortization | 11.11% | 17.21% | 41.18% | 53.01% | 41.57% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 122.96% | 92.52% | 87.78% | 36.35% | 0.59% |
Change in Net Operating Assets | -124.14% | 56.02% | -94.92% | 105.08% | 455.73% |
Cash from Operations | -130.84% | -15.57% | -44.77% | -4.39% | -6.69% |
Capital Expenditure | 93.40% | 89.71% | 99.00% | 37.35% | -993.02% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 114.46% | 75.96% | 104.84% | -- | -- |
Cash from Investing | 114.39% | 77.20% | 104.82% | 26,072.29% | -337,088.37% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -6.57% | -98.91% | 117.90% | 59.10% | 68.65% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 56.30% | -98.91% | 117.90% | 59.10% | 0.81% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 98.56% | -95.54% | 92.43% | 126.26% | -1,567.48% |